BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

22 hedge funds and large institutions have $1.49M invested in Biolase, Inc. in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
1
Perkins Capital Management
Minnesota
$766K
2
AIC
2
AWM Investment Company
New York
$545K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$39K
4
VF
4
Virtu Financial
New York
$17K
5
ZF
5
Zhang Financial
Michigan
$5.88K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$26.5K
2
HF
2
HRT Financial
New York
$0
3
TSS
3
Two Sigma Securities
New York
$0
4
BlackRock
4
BlackRock
New York
$33.3K
5
Morgan Stanley
5
Morgan Stanley
New York
$363
Name Holding Trade Value Shares
Change 		Shares
Change %
TSS
26
Two Sigma Securities
New York
– -$7.24K -111 Closed
1
2